Skip to content

Surgical Treatment for proliferative Diabetic Retinopathy

Surgical Treatment for proliferative Diabetic Retinopathy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900023182
Enrollment
Unknown
Registered
2019-05-15
Start date
2019-05-20
Completion date
Unknown
Last updated
2019-05-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic Retinopathy

Interventions

Case series:none

Sponsors

Tianjin Eye Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. aged = 18 years; 2. patients who had diabetic vitrectomy due to PDR, including non-clearing vitreous hemorrhage more than 3 months, fibrovascular membranes of the retina, or traction retinal detachment (TRD)

Exclusion criteria

Exclusion criteria: 1. Eyes with a history of glaucoma, neovascularization of the iris (NVI), ocular trauma, uveitis, intraocular injection or vitrectomy, or evidence of other vitreoretinal disease; 2. patients which is not satisfied with glycemic or blood pressure control before surgery.

Design outcomes

Primary

MeasureTime frame
Best correct visual acuity;

Countries

China

Contacts

Public ContactYue Zhang

Tianjin Eye Hospital

zhongguol985@163.com+86 15602061989

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026